Mostrando 6 resultados de: 6
Filtros aplicados
Subtipo de publicación
Article(6)
Publisher
Genes(1)
International Journal of Gynecological Cancer(1)
Life Sciences(1)
OncoTargets and Therapy(1)
Oncology Reports(1)
Área temáticas
Enfermedades(4)
Farmacología y terapéutica(2)
Fisiología y materias afines(2)
Bioquímica(1)
Fisiología humana(1)
Origen
scopus(6)
Astemizole-based anticancer therapy for hepatocellular carcinoma (HCC), and Eag1 channels as potential early-stage markers of HCC
ArticleAbstract: Hepatocellular carcinoma (HCC) has very poor prognosis. Astemizole has gained great interest as a poPalabras claves:Astemizole, Eag1, Liver cancer, Liver cirrhosis, Potassium channels, tumor markersAutores:Acuña-Macías I., Caro-Sánchez C.H., Chiliquinga A.J., de Guadalupe Chávez-López M., Díaz-Chávez J., Gariglio P., Hernández-gallegos E., Herrera L.A., Javier Camacho, Pérez-Carreón J.I., Zúñiga-García V.Fuentes:scopusAntiproliferative and proapoptotic effects of astemizole on cervical cancer cells
ArticleAbstract: Objective: Cervical cancer is a major cause of mortality among women in developing countries. Thus,Palabras claves:Astemizole, Cervical Cancer, Ether à-go-go, Imipramine, Potassium channelsAutores:de Guadalupe Chávez-López M., Gariglio P., Hernández-gallegos E., Javier Camacho, Vázquez-Sánchez A.Y.Fuentes:scopusEag1 gene and protein expression in human retinoblastoma tumors and its regulation by pRb in HeLa cells
ArticleAbstract: Retinoblastoma is the most common pediatric intraocular malignant tumor. Unfortunately, low cure ratPalabras claves:Astemizole, Eag1 channels, KCNH1, Kv10.1, Potassium channels, Retinoblastoma, tumor suppressorAutores:Avalos-fuentes A., Cabrera-muñoz M.d.L., Castro-Magdonel B.E., Chávez-lópez M.d.G., Escobar Y., Garrido E., Hernández-gallegos E., Javier Camacho, Ortiz C.S., Ponce-castañeda M.V., Sanchez-Ramos J., Vera E., Zúñiga-García V.Fuentes:scopusEag1 potassium channels as markers of cervical dysplasia
ArticleAbstract: Human ether à-go-go 1 (Eag1) potassium channels are potential tumor markers and therapeutic targetsPalabras claves:Cervical Cancer, estrogens, Human ether à-go-go 1, Potassium channels, tumor markersAutores:Aguilar-Guadarrama R., Gamboa-Dominguez A., Garcia-Villa E., Gariglio P., Hernández-gallegos E., Hinojosa L.M., Javier Camacho, Martínez-Benítez B., Montante-Montes D., Ortiz C.S., Pardo L.A., Ramírez A., Saqui-Salces M., Solís-Pancoatl M., Stühmer W.Fuentes:scopusEffect of extracellular matrix on adhesion, viability, actin cytoskeleton and K<sup>+</sup> currents of cells expressing human ether à go-go channels
ArticleAbstract: Ether à go-go (EAG) potassium channels possess oncogenic properties and have gained great interest aPalabras claves:actin, Cáncer, collagen, Cytoskeleton, Ether à-go-go, extracellular matrix, fibronectin, Potassium channels, ProliferationAutores:Azorín E., Delgadillo D.M., Gomora J.C., Hernández-gallegos E., Javier Camacho, Mendoza-Garrido M.E., Solano-Agama C., Toral C.Fuentes:scopusThe combination astemizole–gefitinib as a potential therapy for human lung cancer
ArticleAbstract: Lung cancer is a major cause of cancer mortality. Thus, novel therapies are urgently needed. RepositPalabras claves:Astemizole, Gefitinib, lung cancer, Potassium channelsAutores:Carmen Alexandra Chasiquiza-Anchatuña, Chávez-lópez M.d.G., Garrido E., Hernández-gallegos E., Javier Camacho, Marco Viteri-Yánez, Sanchez-Ramos J., Vera E., Zúñiga-García V.Fuentes:scopus